The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Precision BioLogic sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Precision BioLogic Inc (Precision BioLogic) is a provider of clinical laboratory products. The company offers diagnostic kits, reagents and controls and specialty plasma. Its diagnostic kits comprise cryocheck clot S, cryocheck clot diluent. Precision BioLogic’s reagents include factor deficient plasma, La check, La sure, platelet lysate and prekallikrein deficient plasma. The company provides specialty plasma products such as abnormal control, APCR positive control, abnormal reference control, heparin control, low fibrinogen control, lupus positive control, normal reference plasma, and others. It also offers customized solutions. Precision BioLogic is headquartered in Dartmouth, Nova Scotia, Canada. Key subsidiaries of Precision BioLogic include Affinity Biologicals.
The key metrics of Precision BioLogic related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Precision BioLogic is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Precision BioLogic.
For a detailed understanding of the performance of Precision BioLogic, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
